Guanglin Xu
发表
Weijie Li,
Lin Wang,
Jing Wang,
2019,
European journal of pharmacology.
Guanglin Xu,
Na Wen,
L. Sheng,
2007,
The Journal of nutritional biochemistry.
Guoyu Pan,
Chen Chen,
Xiaoting Tian,
2015,
Drug Metabolism and Disposition.
Guoyu Pan,
Xiaoting Tian,
Chenggang Huang,
2014
.
Y. Cycowicz,
D. Rodriguez-Moreno,
Guanglin Xu,
2022,
Appetite.
Weijie Li,
Guanglin Xu,
Yujian Li,
2022,
European journal of pharmacology.
Jiquan Yang,
Wenli Zhou,
Jing Wang,
2016,
Oncotarget.
Z. Yin,
Zhongjun Li,
Yue-tao Zhao,
2012,
PloS one.
Ping Wu,
C. Cai,
Hui Zhang,
2011,
The Analyst.
Y. Wang,
Li-Tai Hu,
Weijie Li,
2018,
Neoplasia.
Qingfen Yu,
Guanglin Xu,
Shumin Pan,
2023,
International immunopharmacology.
Heng Song,
Guanglin Xu,
Guizhen Ao,
2016,
Journal of enzyme inhibition and medicinal chemistry.
Jing Wang,
Guanglin Xu,
Yi Zhang,
2016,
Cellular Physiology and Biochemistry.
Bortezomib inhibits hepatocellular carcinoma via the Hippo‐Yes‐associated protein signalling pathway
Guanglin Xu,
Shumin Pan,
Kejun Hu,
2022,
Basic & clinical pharmacology & toxicology.
Li-Tai Hu,
Weijie Li,
Ying Wang,
2017,
Journal of experimental & clinical cancer research : CR.
Li-Tai Hu,
Weijie Li,
Ying Wang,
2017,
Journal of Experimental & Clinical Cancer Research.
Ping Wu,
C. Cai,
Hui Zhang,
2011,
The Analyst.